• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭患者管理干预措施经济分析工具介绍:成本核算工具:一个用户友好的电子表格程序,用于估算提供以患者为中心的干预措施的成本。

Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions.

作者信息

Reed Shelby D, Li Yanhong, Kamble Shital, Polsky Daniel, Graham Felicia L, Bowers Margaret T, Samsa Gregory P, Paul Sara, Schulman Kevin A, Whellan David J, Riegel Barbara J

机构信息

Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA.

出版信息

Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):113-9. doi: 10.1161/CIRCOUTCOMES.111.962977. Epub 2011 Dec 6.

DOI:10.1161/CIRCOUTCOMES.111.962977
PMID:22147884
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3261318/
Abstract

BACKGROUND

Patient-centered health care interventions, such as heart failure disease management programs, are under increasing pressure to demonstrate good value. Variability in costing methods and assumptions in economic evaluations of such interventions limit the comparability of cost estimates across studies. Valid cost estimation is critical to conducting economic evaluations and for program budgeting and reimbursement negotiations.

METHODS AND RESULTS

Using sound economic principles, we developed the Tools for Economic Analysis of Patient Management Interventions in Heart Failure (TEAM-HF) Costing Tool, a spreadsheet program that can be used by researchers and health care managers to systematically generate cost estimates for economic evaluations and to inform budgetary decisions. The tool guides users on data collection and cost assignment for associated personnel, facilities, equipment, supplies, patient incentives, miscellaneous items, and start-up activities. The tool generates estimates of total program costs, cost per patient, and cost per week and presents results using both standardized and customized unit costs for side-by-side comparisons. Results from pilot testing indicated that the tool was well-formatted, easy to use, and followed a logical order. Cost estimates of a 12-week exercise training program in patients with heart failure were generated with the costing tool and were found to be consistent with estimates published in a recent study.

CONCLUSIONS

The TEAM-HF Costing Tool could prove to be a valuable resource for researchers and health care managers to generate comprehensive cost estimates of patient-centered interventions in heart failure or other conditions for conducting high-quality economic evaluations and making well-informed health care management decisions.

摘要

背景

以患者为中心的医疗保健干预措施,如心力衰竭疾病管理项目,在证明其良好价值方面面临越来越大的压力。此类干预措施经济评估中成本计算方法和假设的差异限制了各研究间成本估计的可比性。有效的成本估计对于进行经济评估以及项目预算和报销谈判至关重要。

方法与结果

我们运用合理的经济原则,开发了心力衰竭患者管理干预经济分析工具(TEAM-HF)成本计算工具,这是一个电子表格程序,研究人员和医疗保健管理人员可使用该程序系统地生成经济评估的成本估计,并为预算决策提供信息。该工具指导用户进行相关人员、设施、设备、用品、患者激励措施、杂项物品和启动活动的数据收集和成本分配。该工具生成项目总成本、每位患者成本和每周成本的估计值,并使用标准化和定制单位成本呈现结果以便进行并列比较。试点测试结果表明该工具格式良好、易于使用且遵循逻辑顺序。使用成本计算工具生成了心力衰竭患者为期12周的运动训练项目的成本估计,发现其与近期一项研究中公布的估计值一致。

结论

TEAM-HF成本计算工具可能成为研究人员和医疗保健管理人员的宝贵资源,用于生成心力衰竭或其他病症中以患者为中心的干预措施的全面成本估计,以进行高质量的经济评估并做出明智的医疗保健管理决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/468c/3261318/91c4f4024132/nihms341976f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/468c/3261318/91c4f4024132/nihms341976f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/468c/3261318/91c4f4024132/nihms341976f1.jpg

相似文献

1
Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions.心力衰竭患者管理干预措施经济分析工具介绍:成本核算工具:一个用户友好的电子表格程序,用于估算提供以患者为中心的干预措施的成本。
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):113-9. doi: 10.1161/CIRCOUTCOMES.111.962977. Epub 2011 Dec 6.
2
Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure.心力衰竭患者管理干预措施经济分析工具:成本效益模型——一个基于网络的程序,旨在评估心力衰竭疾病管理项目的成本效益。
Am Heart J. 2015 Nov;170(5):951-60. doi: 10.1016/j.ahj.2015.08.015. Epub 2015 Aug 20.
3
Using standardized tools to improve immunization costing data for program planning: the cost of the Colombian Expanded Program on Immunization.利用标准化工具改进免疫规划成本数据:哥伦比亚扩大免疫规划成本。
Vaccine. 2013 Jul 2;31 Suppl 3:C72-9. doi: 10.1016/j.vaccine.2013.05.038.
4
Understanding cost data collection tools to improve economic evaluations of health interventions.理解成本数据收集工具,以改善健康干预措施的经济评估。
Stroke Vasc Neurol. 2019 Dec 1;4(4):214-222. doi: 10.1136/svn-2019-000301. eCollection 2019 Dec.
5
Lives Saved Tool (LiST) costing: a module to examine costs and prioritize interventions.挽救生命工具(LiST)成本核算:一个用于检查成本并确定干预措施优先级的模块。
BMC Public Health. 2017 Nov 7;17(Suppl 4):782. doi: 10.1186/s12889-017-4738-1.
6
Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.近期心力衰竭出院患者的家庭远程监测或结构化电话支持计划:系统评价和经济评估。
Health Technol Assess. 2013 Aug;17(32):1-207, v-vi. doi: 10.3310/hta17320.
7
Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial.肺动脉压力引导的心力衰竭管理:使用CHAMPION临床试验结果进行的美国成本效益分析。
Eur J Heart Fail. 2017 May;19(5):652-660. doi: 10.1002/ejhf.642. Epub 2016 Sep 19.
8
Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial: A Secondary Analysis of a Randomized Clinical Trial.REHAB-HF 试验中老年急性心力衰竭患者康复治疗的经济结局:一项随机临床试验的二次分析。
JAMA Cardiol. 2022 Feb 1;7(2):140-148. doi: 10.1001/jamacardio.2021.4836.
9
Digital interventions in mental health: evidence syntheses and economic modelling.数字干预在精神健康中的应用:证据综合和经济建模。
Health Technol Assess. 2022 Jan;26(1):1-182. doi: 10.3310/RCTI6942.
10
Assessing the incremental costs and savings of introducing electronic immunization registries and stock management systems: evidence from the better immunization data initiative in Tanzania and Zambia.评估引入电子免疫登记和库存管理系统的增量成本与节省情况:来自坦桑尼亚和赞比亚更好免疫数据倡议的证据
Pan Afr Med J. 2020 Feb 12;35(Suppl 1):11. doi: 10.11604/pamj.supp.2020.35.1.17804. eCollection 2020.

引用本文的文献

1
Program Cost and Return on Investment of a Remote Patient Monitoring Program for Hypertension Management.高血压管理远程患者监测项目的项目成本与投资回报率
medRxiv. 2025 Jan 29:2025.01.29.25321334. doi: 10.1101/2025.01.29.25321334.
2
Home-based mobile-guided exercise-based cardiac rehabilitation among patients undergoing transcatheter aortic valve replacement (REHAB-TAVR): protocol for a randomised clinical trial.基于家庭的移动引导运动为基础的心脏康复在经导管主动脉瓣置换术(REHAB-TAVR)患者中的应用:一项随机临床试验方案。
BMJ Open. 2024 Mar 7;14(3):e080042. doi: 10.1136/bmjopen-2023-080042.
3
Meaning-centered pain coping skills training for patients with metastatic cancer: Protocol for a randomized controlled efficacy trial.

本文引用的文献

1
Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure.心力衰竭:运动训练效果的对照试验(HF-ACTION)随机对照试验的经济学评估:一项针对慢性心力衰竭患者的运动训练研究。
Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):374-81. doi: 10.1161/CIRCOUTCOMES.109.907287. Epub 2010 Jun 15.
2
Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension.高血压患者家庭血压监测(带或不带电话行为自我管理)的经济评价。
Am J Hypertens. 2010 Feb;23(2):142-8. doi: 10.1038/ajh.2009.215. Epub 2009 Nov 19.
3
意义中心疼痛应对技能训练对转移性癌症患者的随机对照疗效试验方案。
Contemp Clin Trials. 2023 Dec;135:107363. doi: 10.1016/j.cct.2023.107363. Epub 2023 Oct 24.
4
Relationship of physical function with quality of life in older patients with acute heart failure.老年急性心力衰竭患者的身体功能与生活质量的关系。
J Am Geriatr Soc. 2021 Jul;69(7):1836-1845. doi: 10.1111/jgs.17156. Epub 2021 Apr 10.
5
Development of a predictive model for integrated medical and long-term care resource consumption based on health behaviour: application of healthcare big data of patients with circulatory diseases.基于健康行为的医疗与长期照护资源消耗综合预测模型的构建:循环系统疾病患者医疗大数据的应用。
BMC Med. 2021 Jan 8;19(1):15. doi: 10.1186/s12916-020-01874-6.
6
Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET).测试一种改善辅助内分泌治疗(AET)依从性的行为干预措施。
Contemp Clin Trials. 2019 Jan;76:120-131. doi: 10.1016/j.cct.2018.11.010. Epub 2018 Nov 22.
7
Study protocol for Log2Lose: A feasibility randomized controlled trial to evaluate financial incentives for dietary self-monitoring and interim weight loss in adults with obesity.“Log2Lose”研究方案:一项可行性随机对照试验,旨在评估对肥胖成年人进行饮食自我监测和中期体重减轻的经济激励措施。
Contemp Clin Trials. 2018 Feb;65:116-122. doi: 10.1016/j.cct.2017.12.007. Epub 2017 Dec 28.
8
Optimizing delivery of a behavioral pain intervention in cancer patients using a sequential multiple assignment randomized trial SMART.使用序贯多重分配随机试验(SMART)优化癌症患者行为疼痛干预措施的实施。
Contemp Clin Trials. 2017 Jun;57:51-57. doi: 10.1016/j.cct.2017.04.001. Epub 2017 Apr 11.
9
Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale.老年急性心力衰竭患者康复治疗(REHAB-HF)试验:设计与原理
Am Heart J. 2017 Mar;185:130-139. doi: 10.1016/j.ahj.2016.12.012. Epub 2016 Dec 28.
10
Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure.心力衰竭患者管理干预措施经济分析工具:成本效益模型——一个基于网络的程序,旨在评估心力衰竭疾病管理项目的成本效益。
Am Heart J. 2015 Nov;170(5):951-60. doi: 10.1016/j.ahj.2015.08.015. Epub 2015 Aug 20.
American Society of Clinical Oncology guidance statement: the cost of cancer care.
美国临床肿瘤学会指导声明:癌症护理的成本
J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6.
4
Completing costs: patients' time.完成成本:患者的时间。
Med Care. 2009 Jul;47(7 Suppl 1):S89-93. doi: 10.1097/MLR.0b013e31819bc077.
5
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association.心血管风险新标志物评估标准:美国心脏协会的科学声明
Circulation. 2009 May 5;119(17):2408-16. doi: 10.1161/CIRCULATIONAHA.109.192278. Epub 2009 Apr 13.
6
Effects of care coordination on hospitalization, quality of care, and health care expenditures among Medicare beneficiaries: 15 randomized trials.护理协调对医疗保险受益人的住院治疗、医疗质量和医疗保健支出的影响:15项随机试验。
JAMA. 2009 Feb 11;301(6):603-18. doi: 10.1001/jama.2009.126.
7
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.《2009年心脏病和中风统计数据更新:美国心脏协会统计委员会及中风统计小组委员会报告》
Circulation. 2009 Jan 27;119(3):e21-181. doi: 10.1161/CIRCULATIONAHA.108.191261. Epub 2008 Dec 15.
8
Incidence and prevalence of heart failure in elderly persons, 1994-2003.1994年至2003年老年人心力衰竭的发病率和患病率
Arch Intern Med. 2008 Feb 25;168(4):418-24. doi: 10.1001/archinternmed.2007.80.
9
The economic costs of substance abuse treatment: updated estimates and cost bands for program assessment and reimbursement.药物滥用治疗的经济成本:用于项目评估和报销的最新估算及成本区间
J Subst Abuse Treat. 2008 Dec;35(4):462-9. doi: 10.1016/j.jsat.2007.12.008. Epub 2008 Feb 21.
10
Cost-effectiveness of telephonic disease management in heart failure.心力衰竭中电话疾病管理的成本效益
Am J Manag Care. 2008 Feb;14(2):106-15.